enow.com Web Search

  1. Ads

    related to: new injectable drug for schizophrenia treatment for children pdf

Search results

  1. Results from the WOW.Com Content Network
  2. FDA approves 1st new drug for schizophrenia in more ... - AOL

    www.aol.com/fda-approves-1st-drug-schizophrenia...

    The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers Squibb ...

  3. Lumateperone - Wikipedia

    en.wikipedia.org/wiki/Lumateperone

    Lumateperone, sold under the brand name Caplyta, is an atypical antipsychotic medication of the butyrophenone class. It is approved for the treatment of schizophrenia as well as bipolar depression, as either monotherapy or adjunctive therapy (with lithium or valproate). [2]

  4. Teva Presents Latest Schizophrenia Treatment Research ...

    lite.aol.com/tech/story/0022/20241101/1001010507.htm

    About Schizophrenia Schizophrenia is a chronic, progressive and severely debilitating mental disorder that affects how one thinks, feels and acts. 2 Patients experience an array of symptoms, which may include delusions, hallucinations, disorganized speech or behavior, and impaired cognitive ability. 2,3,4 Approximately 1% of the world’s ...

  5. Iloperidone - Wikipedia

    en.wikipedia.org/wiki/Iloperidone

    Iloperidone is indicated for the treatment of schizophrenia and mania or mixed episodes in bipolar I disorder. [2] [3] In a 2013 study in a comparison of 15 antipsychotic drugs in effectivity in treating schizophrenic symptoms, iloperidone demonstrated mild effectiveness -- as effective as lurasidone, and 13 to 15% less effective than ziprasidone, chlorpromazine, and asenapine. [4]

  6. Brilaroxazine - Wikipedia

    en.wikipedia.org/wiki/Brilaroxazine

    RECOVER-2 is a confirmatory 4-week, randomized, double-blind, placebo-controlled, multicenter phase III clinical trial of 450 acute schizophrenia patients, where patients will receive brilaroxazine 30 mg, 50 mg, or placebo once daily. Completion is expected in Q2 2025 and brilaroxazine FDA new drug application (NDA) submission is expected in Q3 ...

  7. This FDA-approved drug promises a new way to treat schizophrenia

    www.aol.com/fda-approved-drug-promises-way...

    The KarXT approval comes after decades of no significant treatment advancements for schizophrenia patients. About 3.7 million, or 1.8%, of adults in the U.S. have a lifetime history of ...

  1. Ads

    related to: new injectable drug for schizophrenia treatment for children pdf